Navidea Biopharmaceuticals (FRA:NO1A) Price-to-Operating-Cash-Flow : (As of May. 20, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Navidea Biopharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-05-20), Navidea Biopharmaceuticals's share price is €0.0665. Navidea Biopharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.13. Hence, Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Navidea Biopharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 30.57. The lowest was 0.93. And the median was 2.20.

FRA:NO1A's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 27.11
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Navidea Biopharmaceuticals's Cash Flow from Operations per share for the three months ended in Sep. 2023 was €-0.10. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.13.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 23.50% per year.

During the past 13 years, Navidea Biopharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 78.10% per year. The lowest was -129.00% per year. And the median was -7.00% per year.

Navidea Biopharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navidea Biopharmaceuticals Price-to-Operating-Cash-Flow Chart

Navidea Biopharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

4.09

Navidea Biopharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Navidea Biopharmaceuticals Price-to-Operating-Cash-Flow Calculation

Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.0665	/	-0.13
	=

Navidea Biopharmaceuticals's Share Price of today is €0.0665.
Navidea Biopharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.13.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Navidea Biopharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Navidea Biopharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Navidea Biopharmaceuticals (FRA:NO1A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Navidea Biopharmaceuticals Inc (FRA:NO1A) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

NAVB:USA

Address

4995 Bradenton Avenue, Suite 240, Dublin, OH, USA, 43017-3552

Website

https://www.navidea.com

Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

Navidea Biopharmaceuticals (FRA:NO1A) Headlines

No Headlines